-
-
-
-
-
-
-
Regulus Therapeutics (RGLS) Announces Successful Completion of its Phase 1b MAD Clinical Trial of Farabursen (RGLS8429) for the Treatment of ADPKD
-
-
-
-
-
-
-
Regulus Therapeutics (RGLS) Misses Q2 EPS by 5c
-
-
-
-
412,934 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

